» Articles » PMID: 2991554

Interstitial Murine Cytomegalovirus Pneumonia After Irradiation: Characterization of Cells That Limit Viral Replication During Established Infection of the Lungs

Overview
Journal J Virol
Date 1985 Aug 1
PMID 2991554
Citations 200
Authors
Affiliations
Soon will be listed here.
Abstract

Interstitial pneumonia associated with viral replication in lung tissue was observed after cytomegalovirus infection of total-body gamma-irradiated mice, whereas in noncompromised hosts the lungs were not affected and virus multiplication was restricted to the salivary glands. The radiation damage could either predispose normally nonpermissive cell types for productive infection or abrogate an immune control of the tissue manifestation of infection by elimination of lymphocytes. Adoptive transfer of lymphoid cells into irradiated, infected recipients supported the second alternative. Even when infection was established in the lungs, as manifested by the presence of infected lung tissue cells in the alveolar septa, an antiviral effect could be assigned to the Lyt-2+, L3T4- subset of T lymphocytes specifically sensitized in the immunocompetent donor. These cells did not require in vitro propagation to perform effector cell functions in vivo and were operative under physiological conditions in comparatively low numbers. Hence, there is reason to assume that T lymphocytes are responsible for the tissue distribution of cytomegalovirus replication during infection.

Citing Articles

Cytomegalovirus inhibitors of programmed cell death restrict antigen cross-presentation in the priming of antiviral CD8 T cells.

Ebert S, Bohm V, Buttner J, Brune W, Brinkmann M, Holtappels R PLoS Pathog. 2024; 20(8):e1012173.

PMID: 39146364 PMC: 11349235. DOI: 10.1371/journal.ppat.1012173.


Immune surveillance of cytomegalovirus in tissues.

Mihalic A, Zeleznjak J, Lisnic B, Jonjic S, Juranic Lisnic V, Brizic I Cell Mol Immunol. 2024; 21(9):959-981.

PMID: 39134803 PMC: 11364667. DOI: 10.1038/s41423-024-01186-2.


Construction and Characterization of a High-Capacity Replication-Competent Murine Cytomegalovirus Vector for Gene Delivery.

Riedl A, Bojkova D, Tan J, Jeney A, Larsen P, Jeney C Vaccines (Basel). 2024; 12(7).

PMID: 39066429 PMC: 11281640. DOI: 10.3390/vaccines12070791.


Innate and adaptive effector immune drivers of cytomegalovirus disease in lung transplantation: a double-edged sword.

Bharti R, Calabrese D Front Transplant. 2024; 3:1388393.

PMID: 38993763 PMC: 11235306. DOI: 10.3389/frtra.2024.1388393.


Mucosal T-cell responses to chronic viral infections: Implications for vaccine design.

Al-Talib M, Dimonte S, Humphreys I Cell Mol Immunol. 2024; 21(9):982-998.

PMID: 38459243 PMC: 11364786. DOI: 10.1038/s41423-024-01140-2.


References
1.
Keil G, Fibi M, Koszinowski U . Characterization of the major immediate-early polypeptides encoded by murine cytomegalovirus. J Virol. 1985; 54(2):422-8. PMC: 254813. DOI: 10.1128/JVI.54.2.422-428.1985. View

2.
Bukowski J, Warner J, Dennert G, Welsh R . Adoptive transfer studies demonstrating the antiviral effect of natural killer cells in vivo. J Exp Med. 1985; 161(1):40-52. PMC: 2187554. DOI: 10.1084/jem.161.1.40. View

3.
Smith M . Propagation of salivary gland virus of the mouse in tissue cultures. Proc Soc Exp Biol Med. 1954; 86(3):435-40. DOI: 10.3181/00379727-86-21123. View

4.
Blanden R . Mechanisms of recovery from a generalized viral infection: mousepox. II. Passive transfer of recovery mechanisms with immune lymphoid cells. J Exp Med. 1971; 133(5):1074-89. PMC: 2138917. DOI: 10.1084/jem.133.5.1074. View

5.
Brody A, Craighead J . Pathogenesis of pulmonary cytomegalovirus infection in immunosuppressed mice. J Infect Dis. 1974; 129(6):677-89. DOI: 10.1093/infdis/129.6.677. View